Literature DB >> 3132032

Successful use of flecainide in atrial fibrillation with rapid ventricular rate in the Wolff-Parkinson-White syndrome.

H J Crijns1, P den Heijer, L M van Wijk, K I Lie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3132032     DOI： 10.1016/0002-8703(88)90032-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  6 in total

Review 1.  Safety of flecainide.

Authors:  Juan Tamargo; Alessandro Capucci; Philippe Mabo
Journal:  Drug Saf       Date:  2012-04-01       Impact factor: 5.606

Review 2.  The pharmacologic treatment of atrial fibrillation.

Authors:  R Bolognesi
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

3.  Near miss paradoxical embolism.

Authors:  J S Wright
Journal:  Br Heart J       Date:  1995-01

Review 4.  Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.

Authors:  Omar F Hassan; Jassim Al Suwaidi; Amar M Salam
Journal:  J Atr Fibrillation       Date:  2013-06-30

Review 5.  Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation.

Authors:  Etienne Aliot; Alessandro Capucci; Harry J Crijns; Andreas Goette; Juan Tamargo
Journal:  Europace       Date:  2010-12-07       Impact factor: 5.214

6.  Pharmacological management of atrial fibrillation: one, none, one hundred thousand.

Authors:  Fabiana Lucà; Mark La Meir; Carmelo Massimiliano Rao; Orlando Parise; Ludovico Vasquez; Rocco Carella; Roberto Lorusso; Benedetto Daniela; Jos Maessen; Gian Franco Gensini; Sandro Gelsomino
Journal:  Cardiol Res Pract       Date:  2011-04-26       Impact factor: 1.866
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.